Wednesday, August 10, 2016

Iconic Therapeutics Adds $10M To Series C

South San Francisco-based Iconic Therapeutics, which is targeting treatments for retinal disease and cancer, said on Tuesday that it has added $10M in funding to its existing, Series C funding round. The new funding came from Xeraya Capital. Iconic Therapeutics has now raised a total of $48.5M in the Series C funding, which had its initial close in January. The funding also includes MPM Capital, HBM Healthcare Investments, H.I.G. BioHealth Partners, Lundbeckfonden Ventures, Cormorant Asset Management, and Osage University Partners.